Drug profile · INN
ibuprofen
APO-IBUPROFEN 400
ibuprofen (APO-IBUPROFEN 400) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — ibuprofen
- US status
- approved
- Class
- Cardiovascular system (C01)
- Route
- ORAL
- Patents
- 15
- Programs
- 31
- Data quality
- 0.89
Quick answer
ibuprofen (APO-IBUPROFEN 400) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11806400
Injectable ibuprofen formulation
granted -
US 9931311
Treating critically ill patients with intravenous ibuprofen
granted -
US 9649284
Treating critically ill patients with intravenous ibuprofen
granted -
US 9295639
Treating critically ill patients with intravenous ibuprofen
granted -
US 9138404
Treating critically ill patients with intravenous ibuprofen
granted -
US 9114068
Treating patients with intravenous ibuprofen
granted -
US 9072661
Injectable ibuprofen formulation
granted -
US 9072710
Injectable ibuprofen formulation
granted -
US 9012508
Administration of intravenous ibuprofen
granted -
US 8871810
Treating critically ill patients with intravenous ibuprofen
granted -
US 8790641
Production of high mannose proteins in plant culture and therapeutic uses thereof
granted -
US 8742079
Saccharide-containing protein conjugates and uses thereof
granted -
US 8735452
Treating patients with intravenous ibuprofen
granted -
US 7655781
Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
granted -
US 6066332
Immediate-effect ibuprofen-containing medicament and its use
expired
Frequently asked questions
What is ibuprofen?
ibuprofen (APO-IBUPROFEN 400) is a cyclooxygenase inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ibuprofen?
APO-IBUPROFEN 400 is a marketed brand name for ibuprofen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibuprofen?
ibuprofen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.